Sherrid MV - Search Results

1

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy.

Ho CY, Mealiffe ME, Bach RG, Bhattacharya M, Choudhury L, Edelberg JM, Hegde SM, Jacoby D, Lakdawala NK, Lester SJ, Ma Y, Marian AJ, Nagueh SF, Owens A, Rader F, Saberi S, Sehnert AJ, Sherrid MV, Solomon SD, Wang A, Wever-Pinzon O, Wong TC, Heitner SB. Ho CY, et al. Among authors: sherrid mv. J Am Coll Cardiol. 2020 Jun 2;75(21):2649-2660. doi: 10.1016/j.jacc.2020.03.064. J Am Coll Cardiol. 2020. PMID: 32466879 Free article. Clinical Trial.

2

Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy.

Sherrid M, Delia E, Dwyer E. Sherrid M, et al. Am J Cardiol. 1988 Nov 15;62(16):1085-8. doi: 10.1016/0002-9149(88)90553-x. Am J Cardiol. 1988. PMID: 3189171

3

An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy.

Sherrid MV, Chu CK, Delia E, Mogtader A, Dwyer EM Jr. Sherrid MV, et al. J Am Coll Cardiol. 1993 Sep;22(3):816-25. doi: 10.1016/0735-1097(93)90196-8. J Am Coll Cardiol. 1993. PMID: 8354817 Free article.

4

Medical treatment of hypertrophic cardiomyopathy.

Sherrid MV, Gunsburg D, Sharma A. Sherrid MV, et al. Curr Cardiol Rep. 2000 Mar;2(2):148-53. doi: 10.1007/s11886-000-0012-7. Curr Cardiol Rep. 2000. PMID: 10980886 Review.

5

Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy.

Sherrid MV, Gunsburg DZ, Moldenhauer S, Pearle G. Sherrid MV, et al. J Am Coll Cardiol. 2000 Oct;36(4):1344-54. doi: 10.1016/s0735-1097(00)00830-5. J Am Coll Cardiol. 2000. PMID: 11028493 Free article.

6

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.

Maron BJ, Carney KP, Lever HM, Lewis JF, Barac I, Casey SA, Sherrid MV. Maron BJ, et al. Among authors: sherrid mv. J Am Coll Cardiol. 2003 Mar 19;41(6):974-80. doi: 10.1016/s0735-1097(02)02976-5. J Am Coll Cardiol. 2003. PMID: 12651044 Free article.

7

Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease.

Yao SS, Qureshi E, Sherrid MV, Chaudhry FA. Yao SS, et al. Among authors: sherrid mv. J Am Coll Cardiol. 2003 Sep 17;42(6):1084-90. doi: 10.1016/s0735-1097(03)00923-9. J Am Coll Cardiol. 2003. PMID: 13678935 Free article.

8

Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.

Sherrid MV, Barac I, McKenna WJ, Elliott PM, Dickie S, Chojnowska L, Casey S, Maron BJ. Sherrid MV, et al. J Am Coll Cardiol. 2005 Apr 19;45(8):1251-8. doi: 10.1016/j.jacc.2005.01.012. J Am Coll Cardiol. 2005. PMID: 15837258 Free article.

9

Gene mutations in apical hypertrophic cardiomyopathy.

Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, Barr S, Karim A, Olson TM, Kamisago M, Seidman JG, Seidman CE. Arad M, et al. Circulation. 2005 Nov 1;112(18):2805-11. doi: 10.1161/CIRCULATIONAHA.105.547448. Circulation. 2005. PMID: 16267253

10

Pathophysiology and treatment of hypertrophic cardiomyopathy.

Sherrid MV. Sherrid MV. Prog Cardiovasc Dis. 2006 Sep-Oct;49(2):123-51. doi: 10.1016/j.pcad.2006.08.001. Prog Cardiovasc Dis. 2006. PMID: 17046437 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page